Name Development Level Target Family
Name Description
bosentan a specific and competitive antagonist at endothelin receptor types ETA and ETB, has a slightly higher affinity for ETA receptors than for ETB receptors, indicated for the treatment of pulmonary arterial hypertension
TCRDv4.6.9
DrugCentral Indication
DrugCentral
bosentan